Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 4Phase 3 3Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

Vomiting 1Solid Tumors 1Nausea 1Leukemia, Myeloid, Acute 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Metoclopramide × Clear all
NCT02135510 2020-03-31

MEDEA

Amsterdam UMC, location VUmc

Phase 3 Completed
249 enrolled
Other solid neoplasm

Solid Tumors

NCT02979548 2017-01-25

Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy

All India Institute of Medical Sciences

Phase 3 Unknown
116 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00003213 2012-07-11

Drugs to Reduce the Side Effects of Chemotherapy

Swiss Cancer Institute

Phase 3 Completed
267 enrolled

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡